Description of the Business and Financial Condition (Details)			3 Months Ended	6 Months Ended	18 Months Ended
	Jul. 25, 2022 position	Feb. 09, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Jun. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2023 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares	Feb. 10, 2021 USD ($) shares
Subsidiary, Sale of Stock [Line Items]
Share price (in dollars per share) | $ / shares		$ 16.00
Convertible notes payable				$ 0			$ 0
Common stock, shares authorized (in shares) | shares		300,000,000		300,000,000		300,000,000
Preferred stock, shares authorized (in shares) | shares		10,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.01		$ 0.01		$ 0.01
Preferred stock, par value (in dollars per share) | $ / shares		$ 0.01
Restructuring charges				$ 3,200,000
Cash and cash equivalents				63,372,000		$ 88,756,000
Accumulated deficit				238,514,000		$ 215,135,000
Subsequent Event
Subsidiary, Sale of Stock [Line Items]
Reduction in force | position	37
Accrued Expenses
Subsidiary, Sale of Stock [Line Items]
Restructuring charges				1,300,000
Other Liabilities, Noncurrent
Subsidiary, Sale of Stock [Line Items]
Restructuring charges				100,000
Forecast
Subsidiary, Sale of Stock [Line Items]
Payments for restructuring					$ 1,400,000
Severance costs			$ 3,300,000
Research and development
Subsidiary, Sale of Stock [Line Items]
Restructuring charges				2,700,000
Payments for restructuring				1,800,000
General and administrative
Subsidiary, Sale of Stock [Line Items]
Restructuring charges				$ 500,000
Convertible Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Convertible preferred stocks outstanding (in shares) | shares							0
IPO and Private Placement
Subsidiary, Sale of Stock [Line Items]
Net proceeds from issuance of common stock upon initial public offering and Concurrent Private Placement, net of discount and commissions		$ 107,000,000
IPO
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares) | shares		5,750,000
Private placement
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares) | shares		1,562,500
Net proceeds from issuance of common stock upon initial public offering and Concurrent Private Placement, net of discount and commissions		$ 25,000,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Shares sold in offering (in shares) | shares		750,000